Effects of Glycated Serum Protein, Homocysteine, and Cystatin-C Levels on Pregnancy Outcomes in Patients with Gestational Diabetes Mellitus

Overview

Journal Pak J Med Sci

Specialty General Medicine

Date 2024 Mar 28

PMID 38544999

Authors

Yuhua Chen

Chunfang Li

Yurong Lei

Fen Zhang

Affiliations

Soon will be listed here.

Abstract

Objective: To explore the effects of serum glycated serum protein (GSP), homocysteine (Hcy) and cystatin-C (Cys-C) levels on pregnancy outcomes in patients with gestational diabetes mellitus (GDM).

Methods: Retrospective selection of 247 pregnant women who underwent normal prenatal examinations in The Yan'an People's Hospital from January 2020 to May 2022 were included in this retrospective study. Among them, 119 were pregnant women with diabetes (GDM-group) and 128 were pregnant women with normal blood glucose (Normal-group). The levels of serum GSP, HCY, CYS-C, and incidence of adverse pregnancy outcomes were compared between the two groups. The clinical value of levels of serum GSP, Hcy, and Cys-C in predicting adverse pregnancy outcomes were analyzed.

Results: Compared with the Normal-group, the overall incidence of adverse pregnancy outcomes, serum GSP, Hcy, and Cys-C levels in the GDM-group were significantly higher (<0.05). Logistic regression analysis showed that the levels of GSP, Hcy, and Cys-C were independent risk factors for adverse pregnancy outcomes in the GDM-group (<0.05). Receiver operating characteristic (ROC) curve showed that the area under the curve (AUC) for diagnosing adverse pregnancy outcomes in pregnant women with GDM using serum GSP, Hcy, and CysC levels alone were 0.817, 0.843, and 0.775, respectively. The AUC of the three indicators combined was 0.921, indicating that this combination has a good predictive value for diagnosing adverse outcomes in GDM-complicated pregnancies.

Conclusions: GDM is associated with a high risk of adverse pregnancy outcomes. Levels of serum GSP, Hcy, and Cys-C are higher in patients with GDM. The higher the levels of GSP, Hcy, and Cys-C, the greater the risk of adverse pregnancy outcomes. Combining these three indicators can effectively predict maternal pregnancy outcomes.

References

Mascarenhas M, Habeebullah S, Sridhar M . Revisiting the role of first trimester homocysteine as an index of maternal and fetal outcome. J Pregnancy. 2014; 2014:123024. PMC: 4027023. DOI: 10.1155/2014/123024. View

Zheng Y, Deng H, Qiao Z, Gong F . Homocysteine level and gestational diabetes mellitus: a systematic review and meta-analysis. Gynecol Endocrinol. 2021; 37(11):987-994. DOI: 10.1080/09513590.2021.1967314. View

Zheng J, Xu J, Zhang Y, Zhou N . Effects of insulin combined with metformin on serum cystatin C, homocysteine and maternal and neonatal outcomes in pregnant women with gestational diabetes mellitus. Exp Ther Med. 2019; 19(1):467-472. PMC: 6909788. DOI: 10.3892/etm.2019.8224. View

Metzger B, Gabbe S, Persson B, Buchanan T, Catalano P, Damm P . International association of diabetes and pregnancy study groups recommendations on the diagnosis and classification of hyperglycemia in pregnancy. Diabetes Care. 2010; 33(3):676-82. PMC: 2827530. DOI: 10.2337/dc09-1848. View

Di Biase N, Balducci S, Lencioni C, Bertolotto A, Tumminia A, Dodesini A . Review of general suggestions on physical activity to prevent and treat gestational and pre-existing diabetes during pregnancy and in postpartum. Nutr Metab Cardiovasc Dis. 2019; 29(2):115-126. DOI: 10.1016/j.numecd.2018.10.013. View

Wojcik M, Zieleniak A, Mac-Marcjanek K, Wozniak L, Cypryk K . The elevated gene expression level of the A(2B) adenosine receptor is associated with hyperglycemia in women with gestational diabetes mellitus. Diabetes Metab Res Rev. 2013; 30(1):42-53. DOI: 10.1002/dmrr.2446. View

Ornoy A, Becker M, Weinstein-Fudim L, Ergaz Z . Diabetes during Pregnancy: A Maternal Disease Complicating the Course of Pregnancy with Long-Term Deleterious Effects on the Offspring. A Clinical Review. Int J Mol Sci. 2021; 22(6). PMC: 7999044. DOI: 10.3390/ijms22062965. View

Seyhanli Z, Seyhanli A, Aksun S, Pamuk B . Evaluation of serum Angiopoietin-like protein 2 (ANGPTL-2), Angiopoietin-like protein 8 (ANGPTL-8), and high-sensitivity C-reactive protein (hs-CRP) levels in patients with gestational diabetes mellitus and normoglycemic pregnant women. J Matern Fetal Neonatal Med. 2021; 35(25):5647-5652. DOI: 10.1080/14767058.2021.1888919. View

Jin H . Increased levels of glycosylated hemoglobin, microalbuminuria and serum cystatin C predict adverse outcomes in high-risk pregnancies with gestational diabetes mellitus. Exp Ther Med. 2020; 19(2):1281-1287. PMC: 6966206. DOI: 10.3892/etm.2019.8336. View

10.

Li X, Li G, Liu Y, Meng F, Han L, Shao Y . Analysis on the Effect of Metformin Hydrochloride Combined with Insulin Pump for Gestational Diabetes Mellitus. Iran J Public Health. 2022; 51(1):96-104. PMC: 8837891. DOI: 10.18502/ijph.v51i1.8298. View

11.

Gong T, Wang J, Yang M, Shao Y, Liu J, Wu Q . Serum homocysteine level and gestational diabetes mellitus: A meta-analysis. J Diabetes Investig. 2016; 7(4):622-8. PMC: 4931215. DOI: 10.1111/jdi.12460. View

12.

Wu Y, Zhang C, Mol B, Kawai A, Li C, Chen L . Early Prediction of Gestational Diabetes Mellitus in the Chinese Population via Advanced Machine Learning. J Clin Endocrinol Metab. 2020; 106(3):e1191-e1205. PMC: 7947802. DOI: 10.1210/clinem/dgaa899. View

13.

Kramer C, Campbell S, Retnakaran R . Gestational diabetes and the risk of cardiovascular disease in women: a systematic review and meta-analysis. Diabetologia. 2019; 62(6):905-914. DOI: 10.1007/s00125-019-4840-2. View

14.

Jiang X, Liang Z, Chen D, Jia J, Hu J, Ling Hu . Correlation of Homocysteine, AHSG, CRP with Insulin Resistance, 25-(OH)2-VitD, Blood Lipids in Gestational Diabetes Patients. Clin Lab. 2021; 67(2). DOI: 10.7754/Clin.Lab.2020.200609. View

15.

Zhang Z, Li J, Hu T, Xu C, Xie N, Chen D . Interventional effect of dietary fiber on blood glucose and pregnancy outcomes in patients with gestational diabetes mellitus. Zhejiang Da Xue Xue Bao Yi Xue Ban. 2021; 50(3):305-312. PMC: 8710269. DOI: 10.3724/zdxbyxb-2021-0115. View

16.

Tian Y, Zhang S, Huang F, Ma L . Comparing the Efficacies of Telemedicine and Standard Prenatal Care on Blood Glucose Control in Women With Gestational Diabetes Mellitus: Randomized Controlled Trial. JMIR Mhealth Uhealth. 2021; 9(5):e22881. PMC: 8188321. DOI: 10.2196/22881. View

17.

Liu Y, Lu L, Yi M, Shen C, Lu G, Jia J . Study on the correlation between homocysteine-related dietary patterns and gestational diabetes mellitus:a reduced-rank regression analysis study. BMC Pregnancy Childbirth. 2022; 22(1):306. PMC: 8994885. DOI: 10.1186/s12884-022-04656-5. View

18.

Bernea E, Uyy E, Mihai D, Ceausu I, Ionescu-Tirgoviste C, Suica V . New born macrosomia in gestational diabetes mellitus. Exp Ther Med. 2022; 24(6):710. PMC: 9634345. DOI: 10.3892/etm.2022.11646. View

19.

Wang H, Li N, Chivese T, Werfalli M, Sun H, Yuen L . IDF Diabetes Atlas: Estimation of Global and Regional Gestational Diabetes Mellitus Prevalence for 2021 by International Association of Diabetes in Pregnancy Study Group's Criteria. Diabetes Res Clin Pract. 2021; 183:109050. DOI: 10.1016/j.diabres.2021.109050. View

20.

Liu J, Zhang J, Hou M, Du W . Clinical efficacy of linagliptin combined with irbesartan in patients with diabetic nephropathy. Pak J Med Sci. 2022; 38(1):52-56. PMC: 8713209. DOI: 10.12669/pjms.38.1.4417. View